ObjectiveTo observe the changes of macular structure and microvessels in eyes with diabetes macular ischemia (DMI). MethodsA retrospective case study. From January 2023 to July 2023, 23 patients of 31 eyes diagnosed with DMI at Tangshan Ophthalmological Hospital were included in this study. Among them, there were 14 males with 23 eyes; Female cases with 8 eyes. Age were (59.5±4.6) years old. According to the DMI grading standard formulated by the research group for early treatment of diabetes retinopathy, the patients were divided into mild DMI group, moderate DMI group, and severe DMI group, with 8, 12, and 11 eyes respectively. The blood flow density (VD), perfusion area (FA), small vessel VD (SVD), inner retinal capillary plexus VD, FA, and outer retinal, choroidal, and ganglion cell complex (GCC) thickness within 1 mm of the macular fovea in retinal superficial vascular plexus (SVP)were measured using a scanning frequency light source optical coherence tomography instrument. The changes in macular structure and microvasculature in the affected eyes of different degrees of DMI groups were compared and observed. Inter group comparisons were conducted using one-way ANOVA or Kruskal Wallis H-test. Spearman correlation analysis was used to analyze the correlation between DMI severity and GCC, outer retina, choroid thickness, VD, FA and SVP VD, SVD and FA in inner retina. ResultsThe GCC (F=70.670), outer retinal thickness (H=12.393), VD (F=105.506), SVD (H=25.300), FA (F=107.655), and VD (H=24.098) and FA (H=25.300) of the retinal SVP in the mild, moderate, and severe DMI groups were compared, and the differences were statistically significant (P＜0.05). There was no statistically significant difference in choroidal thickness (H=2.441, P＞0.05). Pairwise comparison between groups: VD, SVD, FA of GCC thickness and SVP, and VD of inner retina were statistically significant between severe DMI group and moderate DMI group, and between moderate DMI group and mild DMI group (P＜0.05). The thickness of outer retina was statistically significant between severe DMI group and moderate DMI group (P＜0.05). Inner retinal FA: there were statistically significant differences between severe DMI group, moderate DMI group and mild DMI group (P＜0.05). The correlation analysis results showed that GCC (rs=－0.918), outer retinal thickness (rs=－0.448), and inner retinal VD (rs=－0.894) and FA (rs=－0.918), as well as VD (rs=－0.919), SVD (rs=－0.924), and FA (rs=－0.939) of retinal SVP, were all negatively correlated with the degree of DMI (P＜0.05). There was no correlation between choroidal thickness and degree of DMI (rs=－0.081, P＞0.05). ConclusionThe thickness of GCC, outer retina and choroid, the VD, SVD, and FA of the retinal SVP, the VD and FA of inner retina are all reduced in eyes with different degrees of DMI, while all of them are negatively correlated with the degree of DMI, except for choroid thickness.
ObjectiveTo observe the multimodal imaging characteristics of tamoxifen retinopathy. MethodsA retrospective case study. From January 2019 to December 2021, 4 patients (8 eyes) with tamoxifen retinopathy diagnosed in Tangshan Eye Hospital were included in the study. All patients were female, with sick binoculus. The age was 59.5±4.6 years. After breast cancer resection, tamoxifen 20 mg/d was taken orally consecutively, including 1, 1, and 2 cases who took tamoxifen orally for 5, 7, and ≥10 years. All eyes were examined by fundus color photography, optical coherence tomography (OCT), OCT angiography (OCTA), fundus fluorescein angiography (FFA), and fundus autofluorescence (AF). The multi-mode image features of the fundus of the affected eyes were observed. ResultsThe yellow white dot crystal like material deposition in the macular area was observed in all eyes. In fundus AF examination, macular area showed patchy strong AF. FFA examination showed telangiectasia and fluorescein leakage in macular area at late stage. OCT showed that punctate strong reflexes could be seen between the neuroepithelial layers in the macular region with the formation of a space between the neuroepithelial layers, the interruption of the elliptical zone (EZ), and the formation of a hole in the outer lamella including 4, 5 and 3 eyes; The thickness of ganglion cells in macular region decreased in 7 eyes. OCTA showed that the blood flow density of the superficial retinal capillary plexus around the arch ring was decreased, and the retinal venules were dilated in 2 eyes; Deep capillary plexus (DCP) showed telangiectasia. ConclusionDeposition of yellowish white dot like crystals can be seen in the macular region of tamoxifen retinopathy; dotted strong reflex between neuroepithelial layers, cavity formation, thinning of ganglion cell layer, EZ middle fissure and outer lamellar fissure; DCP capillaries and venules around the arch were dilated; telangiectasia in macular region; flaky strong AF in macular region.
ObjectiveTo observe and analyze the subfoveal choroidal thickness (SFCT), large choroidal vessel layer thickness (LCVT), and their early changes, and to evaluate their prognostic value for treatment outcomes in eyes with polypoidal choroidal vasculopathy (PCV) receiving anti-vascular endothelial growth factor (VEGF) therapy. MethodsA retrospective clinical study. A total of 120 patients (120 eyes) with unilateral PCV diagnosed and confirmed at Tangshan Eye Hospital from January 2020 to August 2024 were included. All affected eyes received intravitreal anti-VEGF injections. SFCT and LCVT were measured using swept-source optical coherence tomography (SS-OCT) before treatment and at 1, 3, 6, and 12 months after treatment. Based on the 12-month follow-up outcomes, the eyes were divided into a good prognosis group (69 eyes) and a poor prognosis group (51 eyes). Subretinal fluid (SRF) absorption was assessed by SS-OCT at 1 month after the first treatment (early stage). Repeated measures ANOVA was used to compare the dynamic changes of SFCT and LCVT between the two groups. Binary logistic regression, joint modeling, receiver operating characteristic (ROC) curves, decision curve analysis (DCA), and mediation analysis were used to evaluate the predictive value of SFCT and LCVT for prognosis. ResultsCompared with the good prognosis group, the poor prognosis group had significantly greater disease duration, best-corrected visual acuity, branching vascular network area, maximum linear lesion distance, proportion of choroidal vascular hyperpermeability, pigment epithelial detachment height, and pre-treatment SFCT and LCVT (P＜0.05). The good prognosis group had significantly lower SRF height (SRFH) before treatment and at 1 month after treatment, and a greater reduction in SRFH (ΔSRFH) within the first month, compared with the poor prognosis group (P＜0.05). At 1 month after treatment, complete SRF absorption was observed in 65 eyes (94.20%, 65/69) in the good prognosis group and 32 eyes (62.75%, 32/51) in the poor prognosis group; the complete SRF absorption rate was significantly higher in the good prognosis group (χ2=18.731, P＜0.001). Repeated measures ANOVA showed that SFCT and LCVT significantly decreased after treatment at different time points in both groups (P＜0.05); at each post-treatment time point, SFCT and LCVT were significantly higher in the poor prognosis group than in the good prognosis group (P＜0.05). Cohen's d effect size analysis showed that the intergroup difference in LCVT was greater than that in SFCT. ROC curve analysis showed that pre-treatment SFCT and LCVT effectively predicted early complete SRF absorption, and LCVT had significantly better diagnostic performance than SFCT [area under the ROC curve (AUC)=0.82, 0.76; P=0.025]. Joint modeling analysis showed that longitudinal changes in SFCT and LCVT were significantly associated with the risk of poor prognosis (P＜0.01); for every 50 μm increase in LCVT and SFCT, the relative risk of poor prognosis was 1.615 and 1.512, respectively. The Akaike information criterion value of the LCVT joint model (3 719.42) was lower than that of the SFCT model (3 852.67). At 1 month after treatment, ΔLCVT and ΔSFCT were both significant predictors of poor prognosis; in all adjusted models, the odds ratio of ΔLCVT was lower than that of ΔSFCT, indicating better predictive value. ROC curve analysis showed that both ΔSFCT and ΔLCVT had significant predictive value for poor prognosis, and ΔLCVT had significantly better predictive performance than ΔSFCT (AUC=0.81, 0.74). DCA showed that both ΔSFCT and ΔLCVT provided clinical net benefit, with ΔLCVT showing higher benefit. Mediation analysis showed that ΔLCVT and ΔSFCT partially improved prognosis by promoting early SRF absorption, with the indirect effect of ΔLCVT (39.35%) being higher than that of ΔSFCT (32.70%). ConclusionsBoth SFCT and LCVT can serve as predictors of prognosis in PCV eyes treated with anti-VEGF therapy. After controlling for the effect of SFCT, LCVT maintains independent predictive value, and its predictive efficacy is superior to that of SFCT.